论文部分内容阅读
目前约50％的原发性肝癌(简称肝癌)不能切除。因此如何进行有效的治疗,是急待解决的问题。本文就中晚期肝癌行肝动脉、门静脉双重插管(HAC·PVC)与单纯肝动脉插管(HAC)化疗的疗效进行比较分析,结果报告如下。
At present, about 50% of primary liver cancer (abbreviated as liver cancer) cannot be removed. Therefore, how to carry out effective treatment is an urgent problem to be solved. This article compares and analyzes the therapeutic effects of hepatic arterial and portal vein dual cannulation (HAC·PVC) and hepatic arterial cannulation (HAC) chemotherapy in advanced and advanced hepatocellular carcinoma. The results are reported below.